Stocks
GlaxoSmithKline (GSK) P/BV US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | -13.1 | 23.3 | -7.15 | -7.81 | -6.73 | -10.3 | ||
| Changes by years, y/y, % | +100% | -277% | -131% | +9% | -14% | +18.9% | |||
GlaxoSmithKline. P/BV
GlaxoSmithKline. P/BV, changes, %
GlaxoSmithKline (GSK) P/BV US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/BV | ? | -6.80 | -7.78 | -8.25 | -6.68 | -11.1 | -10.3 | |
| Changes by years, y/y, % | -31% | -137% | -24% | -15% | +64% | |||
| Changes by quarters, q/q, % | -13% | +14% | +6% | -19% | +66% | |||
